Published in Clin Exp Immunol on December 01, 2005
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood (2006) 4.46
Immunology and homeopathy. 3. Experimental studies on animal models. Evid Based Complement Alternat Med (2006) 1.14
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma. J Immunother (2008) 1.04
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients. Cancer Immunol Immunother (2011) 1.04
Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients. J Transl Med (2006) 0.93
Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo. Blood (2007) 0.89
Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate. J Transl Med (2011) 0.88
Optimizing dendritic cell-based approaches for cancer immunotherapy. Yale J Biol Med (2014) 0.85
Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients. Br J Cancer (2013) 0.84
Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer. Am J Immunol (2009) 0.81
Tolerogenic dendritic cells derived from donors with natural rubber latex allergy modulate allergen-specific T-cell responses and IgE production. PLoS One (2014) 0.80
Tumor cell lysates as immunogenic sources for cancer vaccine design. Hum Vaccin Immunother (2014) 0.80
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade. J Immunol Res (2016) 0.80
The role of Toll-like receptor 4 polymorphisms in vaccine immune response. Pharmacogenomics J (2015) 0.77
Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells. Immunology (2014) 0.77
Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors. Inflammation (2015) 0.76
Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4+ T cell response against MC38 colon carcinoma. Int J Oncol (2015) 0.75
The war on cancer: a report from the front lines. Proc (Bayl Univ Med Cent) (2006) 0.75
Autologous peripheral blood mononuclear cell recognition of autologous proliferating tumor cells in the context of a patient-specific vaccine trial. J Biomed Biotechnol (2011) 0.75
Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections. Front Immunol (2017) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med (1998) 11.03
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med (1985) 8.21
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (1986) 8.07
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA (1994) 6.36
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med (1994) 5.67
CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity (2004) 5.48
Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med (1996) 5.32
Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science (1984) 4.90
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. J Immunol (1995) 4.31
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med (1996) 3.01
Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res (2001) 3.01
Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol (2001) 2.89
The first 1000 dendritic cell vaccinees. Cancer Invest (2003) 2.44
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med (1996) 2.32
Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol (1994) 2.19
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med (1997) 2.12
Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med (1995) 1.78
Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer (1986) 1.60
Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol (2004) 1.58
The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity. J Immunol (2003) 1.54
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer. J Clin Oncol (1989) 1.46
Cutting edge: innate immune system discriminates between RNA containing bacterial versus eukaryotic structural features that prime for high-level IL-12 secretion by dendritic cells. J Immunol (2004) 1.38
Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann N Y Acad Sci (1996) 1.34
Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J Immunol (2000) 1.32
Large-scale culture and selective maturation of human Langerhans cells from granulocyte colony-stimulating factor-mobilized CD34+ progenitors. J Immunol (2000) 1.30
Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. J Immunol (1999) 1.28
Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology (2005) 1.25
Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression. Infect Immun (2005) 1.15
Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother (2002) 1.12
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol (1998) 1.12
Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma. J Immunother (2001) 1.09
Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. J Immunol Methods (2002) 1.08
Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy. Cytotherapy (2001) 1.03
Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br J Cancer (2002) 1.00
Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Clin Cancer Res (2000) 0.92
Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells. Cancer Res (1997) 0.86
Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays. Cytokine (2004) 0.85
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells. Immunology (2004) 0.85
Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives. Hum Cell (2003) 0.84
Clinical application of dendritic cells in cancer vaccination therapy. APMIS (2003) 0.83
Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulation. Cancer Immunol Immunother (2003) 0.83
Clinical applications of dendritic cell cancer vaccines. Oncologist (1999) 0.81
The novel differentiation of human blood mononuclear cells into CD1a-negative dendritic cells is stimulated in the absence of exogenous cytokines by an extract prepared from pinecones. Int Immunopharmacol (2003) 0.81
Monocyte-derived CD1a+ dendritic cells generated in two different culture systems: immunophenotypic and functional comparison. Scand J Immunol (2003) 0.78
Efficient harvest of in vivo IL-2-activated CD3+ lymphocytes for adoptive immunotherapy by selective leukapheresis (lymphocytapheresis). J Hematother (1997) 0.77
Generic queries for meeting clinical information needs. Bull Med Libr Assoc (1993) 8.13
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80
The MEDLINE Button. Proc Annu Symp Comput Appl Med Care (1992) 3.54
Evidence for the geographic spread of a methicillin-resistant Staphylococcus aureus clone between Portugal and Spain. J Clin Microbiol (1995) 3.45
Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J Clin Microbiol (2006) 3.36
Serotyping Streptococcus pneumoniae by multiplex PCR. J Clin Microbiol (2003) 3.00
Rapid fluorescence method for screening Salmonella spp. from enteric differential agars. J Clin Microbiol (1990) 2.84
Competence in the context of adversity: pathways to resilience and maladaptation from childhood to late adolescence. Dev Psychopathol (1999) 2.72
[Socioeconomic determinants and utilization of emergency hospital services]. Med Clin (Barc) (1997) 2.57
Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis (1998) 2.33
Sclerosing mesenteritis: imaging findings in 17 patients. AJR Am J Roentgenol (1999) 2.30
Identification of positive-acting domains in GCN2 protein kinase required for translational activation of GCN4 expression. Mol Cell Biol (1990) 2.26
From ICD9-CM to MeSH using the UMLS: a how-to guide. Proc Annu Symp Comput Appl Med Care (1993) 2.24
The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect (2003) 2.07
In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis. Int J Antimicrob Agents (2002) 2.07
Value of microscopy in the diagnosis of dysentery associated with invasive Entamoeba histolytica. J Clin Pathol (1994) 2.03
Conserved regulation of proximodistal limb axis development by Meis1/Hth. Nature (1999) 2.03
Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis (2005) 2.00
Management of giant anal condyloma by wide local excision and anoplasty. Colorectal Dis (2012) 1.99
Role of the PI3K regulatory subunit in the control of actin organization and cell migration. J Cell Biol (2000) 1.94
NG2-positive cells in the mouse white and grey matter display distinct physiological properties. J Physiol (2004) 1.91
A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol (2001) 1.89
Morbidity of laparoscopic surgery for complicated appendicitis: an international study. Surg Endosc (2006) 1.84
Benefits of laparoscopy and the Jones technique for the nonpalpable testis. J Urol (1997) 1.81
Prevalence of depression and depression recognition in nursing homes. Soc Psychiatry Psychiatr Epidemiol (2001) 1.78
Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 1.78
LAGE-1, a new gene with tumor specificity. Int J Cancer (1998) 1.76
Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. Am J Gastroenterol (2013) 1.74
Analysis of electroencephalograms in Alzheimer's disease patients with multiscale entropy. Physiol Meas (2006) 1.73
Oral cysticercosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1995) 1.72
Pesticide exposure and creatinine variation among young children. J Expo Anal Environ Epidemiol (2001) 1.71
Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats. Diabetologia (2005) 1.69
A 38-kD Mycobacterium tuberculosis antigen associated with infection. Its isolation and serologic evaluation. Clin Exp Immunol (1989) 1.69
Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye (Lond) (2009) 1.68
Radio imaging of the very-high-energy gamma-ray emission region in the central engine of a radio galaxy. Science (2009) 1.66
Very-high-energy gamma rays from a distant quasar: how transparent is the universe? Science (2008) 1.65
Systematic approach for severe respiratory failure due to novel A (H1N1) influenza. Minerva Anestesiol (2011) 1.54
Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications. Int J Colorectal Dis (2003) 1.52
Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell-and natural killer cell-mediated cytotoxicity. Eur J Immunol (1996) 1.51
Cisapride reduces postoperative gastrocaecal transit time after cardiac surgery in children. Intensive Care Med (1996) 1.50
Loss- and gain-of-function mutations show a polycomb group function for Ring1A in mice. Development (2000) 1.50
The role of plasma amino acids in hepatic encephalopathy. Surgery (1975) 1.49
Generating MEDLINE search strategies using a librarian knowledge-based system. Proc Annu Symp Comput Appl Med Care (1993) 1.46
Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and B16F1 tumor cells. Lab Invest (1992) 1.45
[Complications associated with percutaneous renal biopsy in Spain, 50 years later]. Nefrologia (2010) 1.43
[Prognostic factors of bacteremia: prospective study]. An Med Interna (2001) 1.43
Treatment of adolescent Blount disease by asymmetric physeal distraction. J Pediatr Orthop (1997) 1.43
Surgical management of urinary incontinence in children with neurogenic sphincteric incompetence. J Urol (2000) 1.43
Treatment with pegylated interferon alpha-2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin. Rev Esp Enferm Dig (2005) 1.43
C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci (2003) 1.42
Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia (2007) 1.42
The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol (1993) 1.41
Foster care: an update. J Am Acad Child Adolesc Psychiatry (1997) 1.40
Photoaggravated allergic contact dermatitis due to topical thiabendazole. Contact Dermatitis (1993) 1.40
Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40
Functional, social and psychosexual adjustment after vaginal reconstruction. J Urol (1999) 1.40
Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness. J Clin Microbiol (2007) 1.40
Complications of central venous catheterization in critically ill children. Pediatr Crit Care Med (2001) 1.39
[Delayed improvement of anemia treated with intravenous iron and epoetin alfa after hip replacement surgery]. Rev Esp Anestesiol Reanim (2005) 1.39
[Labeling of injectable drugs used in anesthesia]. Rev Esp Anestesiol Reanim (2011) 1.39
Clinical relevance of T-cell receptor delta gene rearrangements in childhood B-precursor cell acute lymphoblastic leukaemia. Br J Haematol (1997) 1.39
[Involvement of histocompatibility and allosensitization in recurrent abortions]. Med Clin (Barc) (1995) 1.38
Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996. J Clin Microbiol (1998) 1.38
[Thrombocytopenia associated with human immunodeficiency virus infection. Immunologic study of 60 patients addicted to parenteral drugs]. Med Clin (Barc) (1993) 1.38
[The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia]. Med Clin (Barc) (1993) 1.38
Brain death and evoked potentials in pediatric patients. Crit Care Med (1999) 1.38
Immediate adverse reaction to aminophylline. Ann Allergy (1993) 1.38
Characterization of the genetic lineages responsible for pneumococcal invasive disease in Portugal. J Clin Microbiol (2005) 1.37
Two beta-glycanase genes are clustered in Bacillus polymyxa: molecular cloning, expression, and sequence analysis of genes encoding a xylanase and an endo-beta-(1,3)-(1,4)-glucanase. J Bacteriol (1991) 1.37
The role of surgery and hyperalimentation in therapy of gastrointestinal-cutaneous fistulae. Ann Surg (1974) 1.37
Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol (1994) 1.36
Spatial and temporal expression of S100B in cells of oligodendrocyte lineage. Glia (2005) 1.34
Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med (2005) 1.33
Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol (1993) 1.33
The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J Immunol (1998) 1.33
Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg (1974) 1.32
Immunochemical identification of Brucella abortus lipopolysaccharide epitopes. Clin Diagn Lab Immunol (1994) 1.31
The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system. Endocrinology (2009) 1.28
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin Microbiol Infect (2008) 1.28
Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck (2000) 1.27
Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats. Endothelial modulation and mechanism involved. Br J Pharmacol (1998) 1.26
Identification of macrolide-resistant clones of Streptococcus pyogenes in Portugal. Clin Microbiol Infect (2006) 1.25
Isolation of the Heterofullerene C59N as Its Dimer (C59N)2. Science (1995) 1.24
Antioxidant supplementation and respiratory functions among workers exposed to high levels of ozone. Am J Respir Crit Care Med (1998) 1.24
Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology (2000) 1.23
Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol (1992) 1.23
Enteroviruses in Spain over the decade 1998-2007: virological and epidemiological studies. J Clin Virol (2009) 1.22
Differentiation of Entamoeba histolytica and Entamoeba dispar cysts using polymerase chain reaction on DNA isolated from faeces with spin columns. Eur J Clin Microbiol Infect Dis (2000) 1.22
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2013) 1.21
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial. Ann Oncol (2005) 1.21
Effectiveness of altered incentives in a food safety inspection program. Prev Med (2001) 1.21
Antioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae. Inflamm Res (1998) 1.21
Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am J Trop Med Hyg (1998) 1.21
Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates. Microb Drug Resist (2004) 1.20
Protein-calorie malnutrition in Candelaria, Colombia. I. Prevalence; social and demographic causal factors. J Trop Pediatr (1967) (1969) 1.19
Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur J Immunol (1998) 1.19
The normal and pathologic ischiorectal fossa at CT and MR imaging. Radiographics (1998) 1.19
Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors. J Med Chem (2000) 1.18